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Abstract
Over the last 10 years we have significantly reduced hospital mortality from sepsis and critical illness. However, the
evidence reveals that over the same period we have tripled the number of patients being sent to rehabilitation settings.
Further, given that as many as half of the deaths in the first year following ICU admission occur post ICU discharge, it is
unclear how many of these patients ever returned home. For those who do survive, the latest data indicate that 50-70%
of ICU “survivors” will suffer cognitive impairment and 60-80% of “survivors” will suffer functional impairment or ICU-
acquired weakness (ICU-AW). These observations demand that we as intensive care providers ask the following
questions: “Are we creating survivors ... or are we creating victims?” and “Do we accomplish ‘Pyrrhic Victories’ in the
ICU?” Interventions to address ICU-AW must have a renewed focus on optimal nutrition, anabolic/anticatabolic
strategies, and in the future employ the personalized muscle and exercise evaluation techniques utilized by elite
athletes to optimize performance. Specifically, strategies must include optimal protein delivery (1.2-2.0 g/kg/day), as an
athlete would routinely employ. However, as is clear in elite sports performance, optimal nutrition is fundamental but
alone is often not enough. We know burn patients can remain catabolic for 2 years post burn; thus, anticatabolic agents
(i.e., beta-blockers) and anabolic agents (i.e., oxandrolone) will probably also be essential. In the near future, evaluation
techniques such as assessing lean body mass at the bedside using ultrasound to determine nutritional status and
ultrasound-measured muscle glycogen as a marker of muscle injury and recovery could be utilized to help find the
transition from the acute phase of critical illness to the recovery phase. Finally, exercise physiology testing that evaluates
muscle substrate utilization during exercise can be used to diagnose muscle mitochondrial dysfunction and to guide a
personalized ideal heart rate, assisting in recovery of muscle mitochondrial function and functional endurance post ICU.
In the end, future ICU-AW research must focus on using a combination of modern performance-enhancing nutrition,
anticatabolic/anabolic interventions, and muscle/exercise testing so we can begin to create more “survivors” and fewer
victims post ICU care.
Introduction
Another such victory ... and we shall be undone.
(Pyrrhus of Epirus)
Over the last 10 years we have significantly reduced
mortality following sepsis and critical illness [1]. Upon
hearing these data most ICU clinicians feel the urge to
“high-five” their colleagues and believe we are winning
the battle against critical illness. But this raises the key
question: “Are we winning many battles in the ICU, but
ultimately losing the war?” Are the battles we are winning
really just “Pyrrhic Victories"? The history of this state-
ment, and perhaps an eye-opening lesson for us as criti-
cal care practitioners, harkens back to the early days of
the Roman Empire (281 BC) when the small Greek city
of Tarentum was threatened with attack by Roman
forces. The small city appealed to the great Greek general
Pyrrhus to save them from the Romans. Pyrrhus, a des-
cendent of Alexander the Great, came to their aid, land-
ing in Italy with an army of 3000 cavalry, 2000 archers,
500 slingers, 20,000 infantry, and 20 war elephants in the
attempt to subdue the Romans. He proceeded to defeat
the Romans at Battle of Heraclea in 280 BC. In victory,
however, Pyrrhus lost 13,000 of his best soldiers, nearly
half of his original force. The following year, Pyrrhus and
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the Romans faced off again in the Battle of Asculum. Pyr-
rhus won what proved to be a backbreaking victory but
losing many thousands of additional men, including most
of his officers. Following the battle, Pyrrhus famously sta-
ted (paraphrase–many translations exists) “Another such
victory and we shall be utterly ruined”. It is from reports
of this semi-legendary event that the term “Pyrrhic vic-
tory” originates. Pyrrhus continued to fight in Italy and
ultimately in Sicily where he took on the empire of
Carthage while also fighting the Romans. He continued
to prove victorious in every battle, but always with heavy
losses. Ultimately, despite never losing a battle, Pyrrhus
was forced to retreat to Greece with only 8000 infantry
and 500 cavalry, with nothing to show for it but a
depleted treasury. Although he initially escaped with his
life, just 2 years later in a battle with Sparta Pyrrhus was
hit on the head by a roof tile thrown by an elderly towns-
woman. Stunned by the blow, he became disoriented and
was beheaded by a Macedonia soldier. Although listed by
Hannibal as perhaps the greatest general to ever live, Pyr-
rhus is now only remembered as a general who won
many battles but ultimately lost his most important war.
What can Pyrrhus teach us as ICU providers? We must
consider that in critical care we are also winning many
battles in our ICUs. As we have reduced mortality from
sepsis by half [1], we have apparently learned to win a
number of battles, including the resuscitation battle with
fluids and vasopressors [2], and we have begun to win
the ventilator-associated injury/acute respiratory distress
syndrome (ARDS) “battle” because mortality from ARDS
in the control group of a recent large ARDSnet trial was
down to a startling 16% [3]. Despite these successful
practices, the same data which indicate we have reduced
sepsis hospital mortality by half in the last 10 years also
show that we “tripled the number of patients going to
rehabilitation” [1]. This begs the following question: of
these “ICU survivors”, how many even survived a year?
Troubling data over the last 10-15 years show that as
much as 40-50% of the mortality within 12 months of an
ICU admission occurs after the patient leaves the unit
[4]. Commonly, patients are placed in a nursing home or
a rehabilitation center, never to return home to their
loved ones or to hold their grandchildren again. Thus,
authors from many leading critical care trials groups are
stating: “Given low ICU mortality ... quality of life, not
mortality should become the focus of future large ICU
trials” [1]. More practically, for all of us as ICU care-
givers, we all must ask ourselves: “Are we creating survi-
vors ... or victims” in our ICU care?
“Are we creating survivors ... or victims?”
To answer this question, perhaps we need to be better at
asking our patients what they think about their quality of
life (QOL) following their stay in our ICUs. One of the
leaders in this field, Dr Wes Ely and his group at Vander-
bilt University have begun to ask these questions of
patients, and his group has created a website [5] for ICU
patients and their families that we as caregivers can gain
great insight from. One of these interviews is with a mid-
dle-aged woman named Melissa who had previously sur-
vived a 2-year battle with leukemia. Unfortunately, many
years later Melissa was diagnosed with influenza pneu-
monia, which unfortunately evolved to ARDS and led to
an ICU stay requiring mechanical ventilation. Following
her ICU stay, Dr Ely and his group interviewed Melissa
and her husband about their experience with ARDS and
recovery from critical illness. In her own words, Melissa
compares her 2-year experience with leukemia and che-
motherapy with her brief experience with ARDS in the
ICU. In a poignant moment she states: “I never dreamed
after having had leukemia and done two years with
chemo ... I never dreamed that anything else could be
worse ... and this was so much worse. It was more spiri-
tually, emotionally, physically, intellectually challenging
than even cancer ... if you presented me ARDS and leuke-
mia ... I would choose the leukemia“ (see Additional file
1). This is a statement that should send chills down the
spine of those of us who have committed our lives to the
care of ICU patients. Undoubtedly we are winning the
battle when it comes to being able to save patients at any
cost and get them “out of the ICU”, but are we winning
the war, especially when it comes to post-ICU QOL?
Melissa goes on to describe her QOL following her ICU
stay as she states “I was so weak I could hardly lift my
limbs off the bed, I could not sit up, and when they got
me into an upright position it was absolutely terrifying ...
I couldn’t walk, I couldn’t stand ... I had to learn how
swallow.” Her husband adds: “I remember when ... the
doctors told me it will be several months in rehab, and I
was like ... but this is only pneumonia? ...” (see Additional
file 2). Of course, we know from the work of Margaret
Herridge [6-8] and others that Melissa’s experience is not
unique. Dr Herridge and her colleagues have shown that
even 40-year-old and 50-year-old ICU patients report
median Short Form-36 (SF-36) physical QOL scores of 0
at 3 and 6 months following an ICU stay for ARDS [6-8].
This marked impairment in QOL persists for 1 year and
often even more than 5 years, as shown in her subse-
quent work. We know that 50% of these patients are not
back at work at 1 year and one-third will never return
to work [6-8]. Overall, recent data indicate that cogni-
tive impairment will affect 50-70% [9] of our ICU
patients and 60-80% [10] will be functionally impaired
post ICU. Without doubt, this is an epidemic. The ques-
tion must then become what can we do to start winning
this war?
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Why are we losing the quality of life war post ICU?
Recent research indicates that the critically ill burn
patient can lose as much as 1 kg lean body mass per day
[11]. Other critically ill patients also suffer significant
lean body mass loss, much of it in the first 7-10 days of
their ICU stay [11]. Patients will gain weight back follow-
ing their ICU stay, but virtually all of this weight is fat
mass, not functional lean body mass [12]. This is not sur-
prising, as data from burn ICU patients demonstrate that
the catabolic/hypermetabolic state following injury can
persist for up to 2 years following discharge from the
hospital and this can markedly hinder recovery of
patients’ lean body mass and function following injury
[13,14]. Further, we as ICU caregivers have not learned
to extend our care beyond the ICU’s borders, such as via
post-ICU rounds and ICU recovery clinics. Given that
patients must be taught how to manage post-ICU regi-
mens such as insulin control of hyperglycemia, why
should we expect patients to be able to intuitively know
how to regain lean body mass and function, especially in
the face of a persistent hypermetabolic/catabolic state?
Many fully healthy individuals and elite athletes pay
millions of dollars each year to professional athletic trai-
ners to “teach” them how to lose fat mass, gain lean body
mass, and improve their physical performance. Who
needs this more than our ICU patients?
Are checklists and bundles the answer after the ICU?
In ICU care we have checklists and bundles for virtually
all of our care. We have guidelines, such as the Surviving
Sepsis Campaign, and pneumonics like “FAST-HUG”
(Feeding, Analgesia, Sedation, Thromboembolic Prophy-
laxis, Head-of-Bed Elevation, Ulcer Prevention, Glucose
Control) for in-ICU care [15]. In improving post-ICU
QOL we have recently been introduced to the ABCDE
bundle [16] for improving long-term outcomes (see
Figure 1). We would advocate that we should add F and
G, with F emphasizing the basic need for Feeding and
early adequate protein and G emphasizing the role for
Gaining function and Growing muscle. ABCDE has been
well described by Dr Ely and others [16], but how do we
achieve the F and the G and perform the research neces-
sary to optimize these key parts of future ICU care?
Our research group is developing an ICU recovery pro-
gram known as “RISEN"–Recovery from ICU via Surveil-
lance, Exercise, and Nutrition. This protocol attempts to
learn and study techniques and practices utilized by elite
athletes, such as Tour de France cyclists and competitive
strength athletes, to benefit our patients’ battle to
become ICU survivors and not ICU victims. This experi-
mental protocol (Table 1) proposes that in order to
optimize post-ICU QOL we must first evaluate the nutri-
tional needs of our patients via accurate metabolic cart
caloric need measurements (so as to prevent underfeed-
ing and overfeeding). The era of “guessing” at caloric
needs with equations must end–we would not guess at
the blood pressure while administering vasopressors, so
why should we guess at caloric needs when the epidemic
of obesity and the increasingly older ICU patient have
proven convincingly that we are not good “guessers” [17].
Figure 1 A ... B ... C ... D ... E ... F ... G ... for post-ICU QOL.QOL quality of life.
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Further, we need to estimate nutritional risk with scores
such as the NUTRIC score [18], so we know in whom
nutrition is more urgently needed; for example, by sup-
plemental parenteral nutrition (PN) to complement ent-
eral feedings. Three very recent large trials have shown
PN to be safer than ever and not associated with high
incidence of infection, as in years past [19-21].
We next need to implement and evaluate bedside lean
body mass and muscle function, perhaps using tests such
as the lean body mass ultrasound and muscle glycogen
ultrasound. Recent data have begun to show that the use
of routine ultrasound techniques (the same ultrasound
used to place central lines present in virtually all ICUs
worldwide) can accurately predict lean body mass [22].
These relatively simple tools appear to be as accurate as
magnetic resonance imaging (MRI) or computed tomo-
graphy (CT) scan lean body mass estimation in patients
and healthy subjects [22]. This technology is currently
being validated in ICU patients, and we have shown it
has excellent inter-rater and intra-rater reliability when
performed by almost any caregiver including dieticians
and nursing staff [23]. This may finally provide an objec-
tive method to identify sarcopenic patients at ICU admis-
sion–those, we believe, who are most at risk for mortality
and impaired post-ICU QOL from poor pre-ICU lean
body mass reserve. Such information will also guide us in
determining who should receive early, aggressive protein
and calorie delivery (via PN and/or enteral nutrition
(EN)) in both clinical trials and clinical practice. We
believe this method will also allow objective evaluation of
the effect of our nutrition and early mobility efforts at
the bedside to reduce loss of lean body mass and, hope-
fully, its recovery [22]. Understanding these processes is
vital, as currently we know that patients who lose 40% of
their lean body mass have an exceedingly high mortality,
with much of this mortality related to lost lean body
mass occurring post ICU discharge [11].
Further, new cutting-edge ultrasound technology is
being utilized by the world’s most elite cyclists in the
Tour de France and other professional sports to directly
measure muscle glycogen within a few minutes [24]. This
proven muscle biopsy technique evaluates the glycogen
storage of the muscle [24]. This technology is utilized by
athletes to predict and prevent overtraining and guide
nutritional needs during training. Glycogen depletion
leads to marked muscle damage and an inability for mus-
cle to recover and become anabolic, as muscle protein
must be broken down for energy when energy cannot be
obtained from glycogen stores. This leads to ongoing cat-
abolism and inability to recover muscle mass and func-
tion [24]. This technique scores muscle glycogen content
on a scale of 0-90, with 90 being optimal or peak muscle
glycogen content in healthy muscle. We have evaluated
numerous athletes and found that the average athlete
who is rested and well nourished will have an average
muscle glycogen score of 73. Following 2 hours and
30 minutes of strenuous cycling or running a marathon,
the score drops to 50-60 (see Figure 2). We used this
muscle glycogen ultrasound technology to assess nine
ICU patients at varying points in their ICU stay as part of
our ICU nutrition program evaluation; that is, in order to
carry out quality assessment of our ICU nutrition deliv-
ery at University of Colorado (not research as defined by
the US Department of Health and Human Services). The
muscle glycogen score averaged 4, with seven of the nine
patients scoring 0, which we have never observed in any
other human population [25]. Thus, one might equate
being in the ICU as similar to continuously running mul-
tiple marathons. We are currently validating this finding
in ICU patients with muscle biopsies to confirm the pre-
vious muscle biopsy validation data performed in healthy
volunteers. Examples of ultrasound pictures obtained
from athletes, sedentary individuals, and an ICU patient
are shown in Figure 3.
What role does nutrition and protein delivery
play in post-ICU outcomes?
Without doubt, lean body mass preservation and recov-
ery of muscle mass and function following critical illness
cannot be achieved without optimal protein and calorie
Table 1. Recovery from ICU via Surveillance, Exercise,
and Nutrition (RISEN) protocol
Day 1 (ICU admission)
Baseline nutritional and metabolic evaluation
Nutrition risk score (NUTRIC score?)
Metabolic evaluation with indirect calorimetry
Baseline muscle evaluation
Lean body mass ultrasound
Muscle glycogen ultrasound
Markers of muscle injury?
CPK-MM (creatine phosphokinase-muscle component)
Myoglobin
LDH-(lactate dehydrogenase)
Every 3-7 days post ICU admission
Ongoing nutritional evaluation
Indirect calorimetry to guide feeding and assess recovery and
mitochondrial function along with lactate measurements.
Muscle evaluation
Lean body mass ultrasound
Muscle glycogen ultrasound
Markers of muscle injury?
CPK-MM
Myoglobin
Physiologic exercise evaluation (when able)
Diagnose exercise/mitochondrial function
Individualized exercise prescription including resistance training to
improve metabolic and musculoskeletal function.
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delivery. Great controversy has arisen recently between
two differing opinions regarding optimal feeding in the
ICU. Traditionally, it has been advocated that patients
receive 80% of full calorie and protein (1.2-2.0 g/kg/day)
feeds in the first week of ICU to optimize outcomes
[26]. However, a number of recent trials have advocated
“trophic feeding” or intentional underfeeding in the first
ICU week, suggesting equal efficacy [27-29]. However, it
is intuitive to most ICU practitioners that “all ICU
patients are not created equal” and undoubtedly “one
size does not fit all”. This concept is well described in a
recent publication from Daren Heyland’s research group
demonstrating that high-risk ICU patients (mechanically
ventilated >8 days) who received low nutritional ade-
quacy in the first week of their ICU stay (<50% of pre-
dicted caloric need) presented increased mortality
(adjusted hazard ratio (HR) = 1.7, 95% confidence inter-
val (CI): 1.1-2.6) versus patients receiving high nutri-
tional adequacy (>80% of calorie needs) after key
covariate adjustment [30]. These data also demonstrate
that for every 25% increase in calorie delivery in the
first ICU week, an improvement in 3-month post-ICU
physical QOL scores (as measured by the SF-36) is
observed. In medical ICU (MICU) patients (typically
found to have greater preillness comorbidities) the effect
of improved nutritional adequacy on QOL was much
stronger with significant improvements in both 3-month
and 6-month SF-36 scores [30]. Importantly, these QOL
improvements are greater than the minimum clinical
important differences (CIDs) for pulmonary disease [31],
found to be meaningful in a patient’s perceived QOL.
Experts in the ICU QOL field have extrapolated these
CIDs in pulmonary disease to post-ICU QOL because
no CIDs for critical illness have been established [32].
CIDs for pulmonary disease are described as a change
of ≥10 on the SF-36 scale for physical functioning and a
≥12.5 point change for role-physical [31]. The data pre-
sented from this recent publication show that for every
25% increase in caloric delivery over the first 8 days in
the MICU, there is a 10.9 point increase in physical
functioning and a 13.1 point increase in role-physical
measures. Thus, a 50 or 75% increase in caloric delivery
Figure 2 Muscle glycogen scores via ultrasound.
Figure 3 Skeletal muscle glycogen content score via ultrasound.
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over the first week of stay in the MICU would be expected
to lead to a 20-30 point change in physical functioning
and a 26-40 point change in role-physical. These changes
would equate to a large change in perceived QOL for ICU
patients following discharge [31]. A recent trial by the
ANZIC’s group has indicated that a 7.8 point change in
physical QOL domain scores is considered clinically rele-
vant based on pilot trial data. These data thus indicate
clinically significant changes in post-ICU QOL may be
achieved even with a 25% increase in caloric delivery dur-
ing the first 8 days of the ICU stay [33].
A major differentiating factor in randomized clinical
trials showing benefit on clinical outcome from reaching
goal nutrition delivery (Table 2) versus trials not
demonstrating a benefit of reaching goal nutrition is
that all trials showing benefit on clinical outcomes
reached a protein delivery of >1.0 g/kg/day in the higher
nutrition delivery group [19,20,27-30,52,53].
Whereas the trials not reaching a protein delivery of
> 1.0 g/kg/d consistently show no benefit of additional
nutrition support versus trophic or permissive under-
feeding in the ICU. As protein is a fundamental building
block of lean body mass, it will be vital to include pro-
tein delivery as a measure in nutrition intervention stu-
dies evaluating QOL.
A great challenge to delivering adequate protein is the
insufficient protein content of most commercial EN
feeds. As a result, survey data have shown that ICU care-
givers worldwide deliver on average 0.6 g/kg/day protein,
not just for the first few days of ICU stay but for the first
12 days or longer [34]. As a result, meeting protein goals
via EN alone has not been successful. Given this, PN
should be considered sooner in higher risk ICU patients
to assist in meeting calorie and protein needs. Three
recent large trials of both supplemental and full total par-
enteral nutrition (TPN) support versus EN in the ICU
setting have shown that TPN use in the ICU is no longer
associated with increased infection risk [19-21].
In summary, the risk of trophic or permissive feeding
in the first week of the ICU stay should not be considered
safe or indicated in higher risk ICU patients, because it
has been associated with increased mortality and impair-
ment of long-term QOL. The greater concern is that cur-
rently we are unable to predict who will prove to be the
“high risk” patients–those who ultimately require pro-
longed mechanical ventilation and become the “long
stayers”. Thus, any wide recommendation for trophic or
permissive underfeeding during the first week of ICU
stay may lead to harm in long-staying ICU patients, who
will only reveal themselves when it is too late to make-up
the calorie and protein debt they have acquired during
their first ICU week [30]. In addition, trials examining
the role of independent parenteral administration of
amino acids/protein have recently been completed or are
underway to help address whether isolated protein deliv-
ery can improve outcome, particularly when combined
with exercise.
Is optimal nutrition delivery enough to optimize
post-ICU quality of life?
The primary author of this article (PEW) has long won-
dered whether nutritional delivery alone during acute ill-
ness was sufficient to optimize preservation of lean body
mass and recover QOL and physical function–and
recently experienced first hand that the answer is no. This
is based on personal experience with nutrition, which
began at age 15 when I was diagnosed with ulcerative coli-
tis and lost 30 kg of body weight over 8 weeks on TPN.
Although undoubtedly TPN saved my life, as it has saved
many lives over the last 40 years, it alone was not able to
prevent a major loss of lean body mass and strength in the
face of a severe inflammatory injury and multiple opera-
tions. I experienced this once again in summer 2014,
when I was in perhaps the best physical condition of my
life (Figure 4). In August 2014 I suffered a complicated
bowel obstruction leading to massive bowel edema and an
emergent operation that led to a brief ICU stay and pro-
longed hospital stay. During this 23-day postoperative
course I lost 20 kg body weight despite being on PN or
oral feeding supplements for the entire period. At dis-
charge, I had lost significant lean body mass and was not
able to walk down the hospital hallway without becoming
short of breath. It took 8 months to recover this weight,
and for the first 3 months I was not even strong enough
to pick up my 5-year-old son.
Without doubt, calorie and protein delivery is manda-
tory to allow for recovery, both clinically and function-
ally, but it alone will not optimize our patients’ chances
to hold their children again. As I have stated in past dis-
cussions [35], we as humans are not evolved to survive
major critical or surgical illness. Mother Nature never
intended us to survive major trauma from the saber-
tooth tiger attack on the caveman, and similarly we are
not evolved to survive major trauma, sepsis, or surgical
interventions. Although we may save many patients
using modern technology and get them out of the ICU,
our lean body mass reserve and overall metabolic
reserve are not sufficient in many cases to allow for a
meaningful QOL again. As previously discussed, hyper-
metabolism and catabolism can persist for months to
years after illness/injury [13,14] and this will require not
only optimal nutrition, but perhaps pharmacologic inter-
vention to overcome.
Lessons from elite athletes: role of anabolic and
anticatabolic agents
To optimize the G in Figure 1, Gaining function and
Growing muscle, we can again look for guidance to
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basic physiology and to our elite athletes who are mas-
ters at gaining and retaining lean body mass. Elite ath-
letes in many sports have proven again and again the
benefits of anabolic and anticatabolic agents that
are now beginning to be employed successfully in acute
illness.
A growing body of literature is beginning to show the
benefits of anticatabolic agents such as beta-blockers in
burn injury and sepsis [36,37]. Dr Herndon was the first to
demonstrate that even a severely burned child could be
made anabolic in the face of a major catabolic stress by
the administration of propranolol [38]. This intervention
also reduced hypermetabolism in this otherwise intractable
catabolic injury. Further, septic shock patients who remain
tachycardic following resuscitation (perhaps a genetic or
evolutionary hypermetabolic tendency in some patients?)
can have their mortality reduced 40% by esmolol adminis-
tration [37]. This is an intervention that has now been
shown to be safe in a number of ICU patient populations
that may finally be able to reverse the persistent hyperme-
tabolism we have “mis-evolved” in modern ICU care.
Future studies are desperately needed focusing on QOL
life following beta-blocker administration.
Further, anabolic agents such as oxandrolone have
shown to be efficacious in reducing the length of stay,
shortening time to wound healing, and improving survival
in major burns [36]. These agents unquestionably improve
lean body mass and function in both patients and athletes.
However, the question remaining unanswered is when to
initiate them? Ideally, these agents (oxandrolone, Growth
Hormone, etc.) would be initiated following the transition
from the “acute phase” to the recovery phase [35] (see
Figure 5). An objective measurement predicting this tran-
sition has yet to be described; we would like to hypothe-
size that a measure of muscle health, like the muscle
glycogen test described previously, could one day be a
measure to signal this transition. We noted that a number
of patients showed recovery of their muscle glycogen (with
scores increasing from 0 to >15) over the first week of ICU
stay. When muscle glycogen scores begin to increase,
we hypothesize patients may be able to sustain anabolism
and be responsive to an anabolic agent like oxandrolone
(Figure 5).
The role of exercise: can we learn from our elite
athletes and teach our patients to exercise
“smarter”?
Optimal nutrition and anticatabolic/anabolic agents will
only be fully successful in improving post-ICU QOL if
we learn to maximize the use and benefit of exercise in
our ICU survivors. Without question, promoting early
mobility improves post-ICU QOL [39]. But can we learn
from our most elite athletes how to diagnose ICU-
induced exercise and muscle mitochondrial dysfunction
and teach our patients how to objectively maximize the
benefits of their exercise efforts? Mitochondrial dysfunc-
tion has been observed in septic patients and is asso-
ciated with severity and outcome in septic shock and in
Figure 4 Lean Body Mass Loss Over 20 days following surgery and critical illness (20 kg over 20 days = 1 kg lean body mass lost/
day).
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the pathogenesis of multiorgan dysfunction syndrome
[40,41]. Moreover, it is well established that mitochon-
drial dysfunction is at the center of the pathogenesis of
insulin resistance (IR) and type 2 diabetes mellitus
(T2DM) [42,43]. This condition causes important meta-
bolic dysregulation and metabolic inflexibility due to the
inability to oxidize fat and CHO properly [44-46], as we
have observed in our exercise physiology laboratory
(Figure 6b). On the opposite end of the metabolic spec-
trum, elite endurance athletes possess the most devel-
oped mitochondria of any humans, which is key for
athletic performance (Figure 6a) [47,48]. Elite athletes in
the Tour De France and other extreme athletic endea-
vors have utilized advanced metabolic and physiological
testing and monitoring (such VO2 max, (maximum
volume of oxygen that a human can use. It is measured
in millilitres per kilogramme of body weight per minute
(ml/kg/min).)
lactate metabolism, and threshold, as well as substrate-
use optimization testing) to target and individualize the
ideal exercise intensities and workload levels they should
be training at to optimize performance. Why should ICU
patients not have access to the same methodologies?
Modern exercise physiology testing and monitoring as
optimized and routinely performed by expert exercise
physiologists, such as the second author of this article
(IS-M), allows for the accurate determination of mito-
chondrial function and substrate utilization by muscle at
increasing workloads (see Figure 6). This allows for an
ideal and individualized exercise intensity (i.e., heart rate)
and workload to be targeted to increase mitochondrial
function and performance efficiency in the forms of
increased lactate clearance capacity and capacity to oxi-
dize fat in the muscle (Figure 6a), which is key for perfor-
mance. This is the same kind of endurance and function
that will allow our ICU survivors to walk up the stairs or
walk down the street again. Muscle depends on both glu-
cose and fat to function. Humans have a quite limited
glycogen reserve (400-600 g) and must then rely on fat
metabolism for any prolonged exercise or activity. For fat
to be used efficiently by the muscle, mitochondrial meta-
bolism must be optimized because fat can only be
oxidized to synthesize ATP in the mitochondria via the
Krebs cycle (Tricarboxylic Acid Cycle (TCA)) and elec-
tron transport chain. Likewise, under resting conditions,
most glucose is oxidized in the mitochondria via pyruvate
oxidation in the TCA. When excessive glycolytic flux
occurs during the stress response (exercise/critical ill-
ness) pyruvate cannot be fully oxidized to acetyl-CoA for
ATP synthesis in the mitochondria. Pyruvate dehydro-
genase (PDH) saturates and drives the reduction of pyru-
vate to lactate increasing blood lactate levels. During
high-intensity exercise, glycolysis is very elevated due to
necessity to synthesize ATP in a fast manner as is elicited
by the critical illness stress response. Therefore, increased
lactate production and hyperlactatetemia as observed in
critical illness are the norm in many forms of athletic
competition. The important difference with ICU patients
is that: well-trained athletes have an excellent lactate
clearance capacity [48,49] due to great mitochondrial
Figure 5 Phases of Critical Care and Metabolic Therapy in ICU. BCAA-Branch Chain Amino Acids. Dysfx-Dysfunction. GH-Growth Hormone.
GLN-Glutamine. TPN-Total Parenteral Nutrition
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capacity, allowing them to continue performing high-
intensity work; and exercise activity ceases at some point
when competition finishes, restoring cellular metabolism
back to basal levels. However, none of this happens in
the ICU because the “race” for survival is 24/7. This is
further complicated by mitochondrial dysfunction, which
results in decreased lactate clearance capacity as has been
described and correlated with ICU survival [50].
It is likely that mitochondrial dysfunction continues
for a prolonged period of time post ICU, contributing to
increased morbidity and decreased lifespan. We have
recently demonstrated this in a patient who presented
to our exercise physiology clinic 6 months following dis-
charge from our burn unit (key identifying information
changed to protect patient identity) [51]. This patient
was a 49-year-old male who presented with a 35% Total
Body Surface Area (TBSA) burn injury. He was in our
burn ICU for 24 days and made a full and uncompli-
cated recovery. He had been an active individual prior
to his injury who enjoyed biking and running. Three
months after hospital discharge he attempted to return
to biking and found that he could not even cycle for
Figure 6 a: Exercise Physiology Testing in World Class Athlete. b: Exercise Physiology Testing in Obesity/Type 2 Diabetes. CHO-
Carbohydrate. HR-Heart Rate.
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5 minutes without becoming quite exhausted, forcing
him to get off his bike and rest for a prolonged period
of time before he was able to bike again, and then only
for a few minutes maximum. He attempted to improve
his endurance for a number of months with no success
at which he point he presented to Dr Inigo San-Millan
and our Exercise Physiology Clinic at the University of
Colorado. Exercise physiology testing was performed
that showed something quite remarkable, and disturb-
ing. This young man, 6 months out from his moderate
to severe burn injury, had absolutely no capacity to uti-
lize fat for energy in his muscle (Figure 7a). This severe
deficit had never been observed in our clinic during
testing of many thousands of subjects. The physiologic
testing was repeated a month later and the same results
were obtained. This finding was found to be consistent
with “exercise metabolic dysfunction” or muscle mito-
chondrial dysfunction. Therefore, we believe that in the
same manner as elite endurance athletes improve their
mitochondrial function through specific and individualized
Figure 7 A - Exercise Physiology Testing in Burn Patient Prior to Metabolic and Exercise Therapy. B - Exercise Physiology Testing in Burn
Patient Following Metabolic and Exercise Therapy. CHO-Carbohydrate. Ox-Oxidation.
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training based on individualized heart rate zones, power
zones, or speed paces, targeted individualized exercise pre-
scription/training through heart rate monitoring could
lead to optimization of physical therapy efforts as part of a
“metabolic rehabilitation” for patients during and after an
ICU stay.
We have discovered that our methodology and tech-
nology can not only target training, but also diagnose
post-illness muscle dysfunction that can lead to serious
impairment of QOL recovery. We applied our metho-
dology with the patient described previously who was
placed on an individualized training plan for 4 months
with specific training zones in the same manner as we
apply to elite athletes. On retesting 4 months later his
ability to utilize fat as a substrate in his muscle had
returned and his heart rate training target adjusted
upward (Figure 7b). Within 1 year following initiation of
training, the patient was fully recovered and competing
in >100 km bike races.
The vital question this raises is how many of our post-
ICU “victims” suffer from this sort of exercise metabolic
dysfunction and mitochondrial dysfunction? It also leads
to a hypothesis that without this targeted performance
testing (available to anyone at many health clubs and
university athletic departments), would any of these
patients (including the burn patient described here) ever
recover? Perhaps this is one explanation for the data of
Herridge et al. [8] showing that the physical QOL
impairments observed following an ICU stay often do
not improve even after 5 years or more following hospi-
tal discharge. This testing can be initiated to guide phy-
sical therapy and exercise while a patient is still
ventilated (perhaps using in-bed ergometers) and con-
tinued throughout the recovery period to give our ICU
patients the best chance to be “survivors” instead of
“victims”.
What can we do to start winning war and create
survivors and not victims after ICU?
In summary, the often “Pyrrhic Victories” of the past
must not be accepted in the future of ICU care. Getting
patients out of the ICU is not enough! We can no
longer take comfort in the improved ICU survival of our
patients when a rapidly growing number will leave to a
nursing home or rehabilitation center where many will
meet their end, never able to walk or hold their grand-
children again. If we cannot learn to address this post-
ICU QOL loss or post-ICU syndrome, one might ask
why we practice intensive care at all? We must learn to
ask our patients what are their goals/reasons for endur-
ing ICU care (perhaps if only to take an evening stroll
with their wife or husband again) and make meeting
these goals by optimizing post-ICU QOL a priority from
the moment they are admitted.
We are learning that this may be as easy as A ... B ...
C ... D ... E ... F ... G ... (Figure 1). But we must pay
attention to these key care pathways from the day of
admission until after discharge. When considering F and
G, nutrition and protein delivery are fundamental to
optimal post-ICU QOL of life. But, to optimize recovery
of QOL, targeted evaluation of the nutritional state (via
the NUTRIC score), lean body mass, and muscle health
(via ultrasound and other modalities) will also be
required. Further, interventions used by athletes world-
wide, such as anabolic/anticatabolic therapy and exercise
physiology testing, must be studied further and imple-
mentation projects performed. Again, why should only
our “healthiest” patients benefit and have access to our
most advanced recovery technologies, when our ICU
patients need and are likely to benefit more from these
innovations than any other “patient"? In closing, if we
are to start creating survivors and not victims following
an ICU stay, we must go to any length to liberate them
from Mother Nature’s desire to prevent their recovery
and utilize all existing innovations to help them win the
war!
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